Covation Biomaterials completes first bio-based chemicals plant
In Vietnam, Vietnam Investment Review reported that Covation Biomaterials, a biomaterials company with advanced technology in the bio-based materials industry, announced that its first commercial plant for the C4 product platform, including bioTHF and bio-based polytetramethylene ether glycol (PTMEG), achieved mechanical completion in April 2026.
In addition, CovationBio said it has now launched the Xatryx brand for the portfolio of new, non-food, bioPTMEG products to be produced at the plant.
The C4 facility is located in Qidong, Jiangsu Province, China. The report stated that the plant is planned in three phases, targeting a future total capacity of 500,000 tons per year of bio-based materials. The first phase, which is now mechanically complete, has a 50,000-ton-per-year commercial production capacity for both bioTHF and bioPTMEG. Commercial production is expected to begin in the second half of 2026, the report added.
Category: Fuels
